Cfm Wealth Partners LLC Eli Lilly & CO Transaction History

Cfm Wealth Partners LLC

$495 Million
Q1 2024

A detailed history of Cfm Wealth Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cfm Wealth Partners LLC holds 7,840 shares of LLY stock, worth $7.31 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

7,840

Previous 4,555 72.12%

Holding current value

$7.31 Million

Previous $2.66 Million 129.72%

% of portfolio

1.23%

Previous 0.61%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $1.95 Million - $2.6 Million	3,285 Added 72.12%	7,840 $6.1 Million
Q4 2023 Jan 11, 2024	BUY	$525.19 - $619.13 $310,387 - $365,905	591 Added 14.91%	4,555 $2.66 Million
Q3 2023 Oct 11, 2023	BUY	$434.7 - $599.3 $8,694 - $11,986	20 Added 0.51%	3,964 $2.13 Million
Q2 2023 Jul 14, 2023	SELL	$350.74 - $468.98 $20,693 - $27,669	-59 Reduced 1.47%	3,944 $1.85 Million
Q1 2023 Apr 12, 2023	BUY	$310.63 - $364.82 $1.24 Million - $1.46 Million	4,003 New	4,003 $1.37 Million

Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $263,570 - $300,366	889 Added 28.25%	4,036 $1.31 Million
Q2 2022 Jul 12, 2022	BUY	$278.73 - $327.27 $104,523 - $122,726	375 Added 13.53%	3,147 $1.02 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $7,510 - $9,333	-32 Reduced 1.14%	2,772 $794,000
Q4 2021 Jan 21, 2022	BUY	$224.85 - $279.04 $47,443 - $58,877	211 Added 8.14%	2,804 $762,000
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $5,096 - $6,272	-23 Reduced 0.88%	2,593 $599,000
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $83,052 - $96,065	-568 Reduced 17.84%	2,616 $387,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $2,619 - $3,241	-22 Reduced 0.69%	3,184 $442,000
Q4 2019 Jan 30, 2020	BUY	$106.92 - $132.43 $342,785 - $424,570	3,206 New	3,206 $453,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $886B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfm Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfm Wealth Partners LLC with notifications on news.

Account

Cfm Wealth Partners LLC Eli Lilly & CO Transaction History